It's been nearly three years since the collapse of Intarcia, a diabetes-focused biotech that had burned through around $2 billion from venture capitalists.
Tomorrow may mark the beginning of its unlikely revival.
Why it matters: More than 30 million Americans have Type 2 diabetes, according to the CDC.
Boston, Minneapolis-St. Paul and San Francisco are among the U.S. hubs where medical device industries are thriving, according to a new report from commercial real estate firm JLL.
Why it matters: While life sciences more broadly have seen shrinking demand for lab space amid a slowdown in investment and hiring, medical devices and medical technologies have emerged as a bright spot, JLL's Life Sciences Industry and Real Estate Perspective shows.
A new analysis finds more than 25% of Medicare Advantage television ads last year used images evoking government Medicare cards — a tactic that's now forbidden under a federal crackdown on misleading advertising in the program.
Why it matters: The fall advertising blitz for Medicare Advantage may look quite different this year because of stricter marketing rules from the Biden administration, the new KFF report indicates.
A new program from Google's artificial intelligence lab DeepMind aims to tackle one of the toughest problems in genetics: sifting through the millions of variations in the human genome to predict those that ultimately cause disease.
Why it matters: The effort could help researchers more quickly zero in on the genes responsible for diseases — especially for rare ones — and identify promising new targets for drug development. But similar tools haven't been widely used, and it would need extensive testing before it could be deployed in medical practice.
Two of the country's biggest unions have joined a coalition calling on federal regulators to protect workers' mental health the way they enforce standards for physical health and safety.
Why it matters: The press comes amid widespread post-pandemic burnout, growing awareness of the country's worsening mental health and some of the strongest pro-union sentiment in decades.
Zocdoc has long been known as the site where patients can scope out doctor reviews and book appointments. But now it's getting into the business of actually running physicians' front offices, the company announced Tuesday.
Why it matters: The company's platform will manage patient intake, handle a practice's entire online scheduling and host telehealth visits — and, for now, the product is entirely free to doctor's offices.
Employers girding themselves for an especially pricey health care benefits season this fall are pushing back harder in negotiations, armed with new price transparency data and emboldened by increased industry scrutiny.
Why it matters: Employers frustrated that they haven't been getting the best deals on health care are using the data to demand better terms in discussions with insurers and pharmacy benefit managers, industry experts said.
